SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
June 6, 2007
-----------------------------
Date of Report (date of earliest event reported)
BIOMERICA, INC.
---------------
(Exact Name of Registrant as Specified in its Charter)
Delaware 0-8765 95-2645573
-------- ------ ----------
(State or Other (Commission (IRS Employer
Jurisdiction of File Number) Identification Number)
Incorporation)
1533 Monrovia Avenue
Newport Beach, California 92663
-------------------------------
(Address of Principal Executive Offices
Including Zip Code)
949-645-2111
------------
(Registrant's Telephone Number,
Including Area Code)
--------------
(Former Name or Former Address if Changed
Since Last Report)
Page 1 of 2 pages
Item 8.01 Other Events -
On June 6, 2007, Biomerica received income of $697,034 on the sale of
Hollister-Stier Laboratories securities it held for investment. The
Hollister-Stier securities were held as an option to purchase shares in
Hollister-Stier Laboratories, LLC and were carried on Biomerica's balance sheet
at a zero value as Hollister-Stier is a private company. The acquisition of
Hollister-Stier Laboratories by Jubilant Organosys Ltd. closed on June 1, 2007.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: June 6, 2007 Biomerica, Inc.
By: /s/ Zackary S. Irani
-------------------------
Zackary S. Irani
Chief Executive Officer